Month: February 2020

NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2019 – Has Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress

SHELTON, CT / ACCESSWIRE / February 24, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the...

Bioactive Adrenomedullin, Measured with Sphingotec’s bio-ADM(R) Assay Plays a Key Role in Septic Shock Patients as Top-Line Results of AdrenOSS-2 Phase II Study Indicate

Bioactive Adrenomedullin is a biomarker for endothelial dysfunction and allows the prediction of septic shock as elevated blood levels of...

error: Content is protected !!